Inflammatory bowel disease (IBD) is a series of non-specific chronic inflammatory diseases, including ulcerative colitis and Crohn’s disease. Besides gastrointestinal symptoms, IBD patients often have extraintestinal symptoms which may involve various systems such as the skeleton and muscle, skin, eyes, liver and gallbladder, pancreas, nerves, urogenital system, lungs, heart, and blood. Biliary diseases are extraintestinal manifestations of IBD and mainly include primary sclerosing cholangitis, IgG4-associated sclerosing cholangitis, primary biliary cirrhosis, and cholelithiasis. Biliary diseases may manifest as transient abnormal liver function in asymptomatic patients and even life-threatening liver failure, and different biliary diseases may have different treatment methods and prognoses and thus require careful differential diagnosis. This article reviews biliary diseases in IBD patients, in order to help clinicians get familiar with the clinical manifestations and diagnosis and treatment strategies for biliary diseases in IBD patients.

In order to examine whether repeated sciatic nerve blocks showed tachyphylaxis and continuity of sciatic nerve with spinal cord affected development of tachyphylaxis when assayed in vivo by duration of depression compound action potentials (CAP), rats were anesthetized with halothane, ventilated, monitored and supported with stable hemodynamics and temperature. Posterior tibial nerve distally and sciatic nerve in thigh were exposed, placed on bipolar silver electrodes for stimulation and recording respectively. Three sequential sciatic nerve blocks were performed between these electrodes using 0.15 ml of 3% chloroprocaine. Nine rats were chosen to observe the effects of repeated sciatic nerve blocks on CAP. In another 18 rats, a second investigator exposed the sciatic nerve near its origin at spinal cord and randomly performed nerve cut and sham (n=9), and closed the incision blinding the electrophysiologic investigator. The results showed that electrical stimulated tibial nerve induced sciatic nerve Aalpha/beta, Adelta, C fiber mediated CAP waves. CAP amplitudes were remained stable during whole experimental procedure. CAP amplitudes were decreased completely with 3% chloroprocaine blocked sciatic nerve and recovered fully. The duration of CAP depression were reduced with repeated blocks. There were no selective blocked effects on Aalpha/beta, Adelta, C fiber mediated CAP. With sciatic nerve cut proximally, there was no statistical significant tachyphylaxis with 3% chloroprocaine repeated blocked sciatic nerve, and the duration of first and third blocked Adelta fiber mediated CAP was 108+/-20 and 92+/-14 min respectively (P>0.05). In normal rats the duration of first and third blocked Adelta fiber mediated CAP was 110+/-20 and 75+/-16 min respectively (P<0.05). It was suggested that tachyphylaxis to local anesthetics can occur in rats repeated blocked sciatic nerve when assayed in vivo by duration of depression CAP. The continuity of sciatic nerve with spinal cord is one of the important factors affecting the development of tachyphylaxis.
Anesthetics, Local/*administration & dosage ; Nerve Block ; Procaine/administration & dosage ; Procaine/analogs & derivatives ; Sciatic Nerve ; *Tachyphylaxis/physiology

Glycine/analogs & derivatives* ; Humans ; Vasculitis, Leukocytoclastic, Cutaneous

Objective: To study the expression of miR-142-5p in lung adenocarcinoma tissues, and to explore its effect on proliferation, invasion, migration and epithelieal-mesenchymal transition (EMT) of H1650 cells and the potential mechanisms. Methods:Atotal of 107 pairs of lung adenocarcinoma tissues and corresponding para-cancerous tissues from patients, who underwent tumor resection and were pathologically confirmed at the Department of Thoracic Surgery, the Fourth Hospital of Hebei Medical University between Jan. 2014 and Jan. 2015, were collected for this study; in addition, human lung adenocarcinoma cell lines (H1650, HCC827, A549, H1975, PC9) and human bronchial epithelial BEAS-2B cells were also used in this study. qPCR was used to detect the expression of miR-142-5p in lung adenocarcinoma tissues and cell lines. The correlation between expression of miR-142-5p and clinical features was analyzed.After transfection with miR-142-5p mimics or miR-negative control (miR-NC) plasmid, the proliferation, invasion and migration of H1650 cells were detected with CCK-8, Transwell invasion assay and Wound healing assay, respectively. The bioinforamtics tool was used to predict the target genes of miR-142-5p, and Luciferase reporter gene assay was performed to validate the regulation of miR-142-5p on target gene. Western blotting (WB) was used to detect the expressions of cyclin-dependent kinase 5 (CDK5) and EMTrelated protein. Results: Compared to Para-cancerous tissues and BEAS-2B cells, the expression of miR-142-5p was lower in lung adenocarcinoma tissues and cell lines (all P<0.01). Of the 107 cases of lung adenocarcinoma tissues, 61 cases (57.01%) showed decreased miR-142-5 expression, which was correlated with the TNM stage and lymph node metastasis (both P<0.01). Transfection of miR-142-5p mimics significantly up-regulated the expression of miR-142-5p and decreased the proliferation, invasion and migration of H1650 cells (all P<0.05 or P<0.01). Bioinformatics showed that CDK5 was a target gene of miR-142-5p. Luciferase reporter gene assay and WB validated that miR-142-5p could significantly down-regulate CDK5 expression in H1650 cells, up-regulate the expression of E-cadherin and down-regulate the expressions of N-cadherin, Twist and Snail in H1650 cells (all P<0.01). Conclusion: miR-142-5p is low expressed in lung adenocarcinoma tissues and cell lines; it suppresses the EMT process to inhibit, invasion and migration of H1650 cells via down-regulating the expression of CDK5.

<B>ObjectiveB>
The purpose of this article is to investigate the extent of depressive symptoms among international students and the characteristics of those at risk.
<B>MethodsB>
Evidence is derived from self-administered questionnaire interviews of 480 international students enrolled in a university in northern Japan. Depressive symptoms are measured using the Center for Epidemiologic Studies Depression scale. The associations of socio-demographic characteristics with depressive symptoms are examined using multiple logistic regression analysis.
<B>ResultsB>
Of the 480 respondents, 197 (41%) have depressive symptoms. The results indicate that gender, course category, and residential arrangement are significantly associated with the risk of having depressive symptoms.
<B>DiscussionB>
Depressive symptoms are relatively prevalent, but these are not a generalized condition since these tend to occur among specific sub-groups of international students. There is a need to further investigate the mental illness so that those with elevated risks are identified and given support.

[摘 要] 目的：探讨芝麻酚（SEM）通过腺苷酸活化蛋白激酶（AMPK）/沉默信息调节因子1（SIRT1）/核因子κB（NF-κB）通路影响食管鳞状细胞癌（ESCC）Eca109细胞自噬和凋亡的机制。方法: 用不同浓度的SEM（0、1.562 5、3.125、6.25、12.5、25、50、100、200、400 μmol/L）分别处理Eca109细胞、人食管上皮细胞HEEpiC 48 h，CCK-8法检测细胞增殖率，筛选适宜的SEM浓度用于后续实验。将Eca109细胞分为对照组（CK组，0 µmol/L）、低剂量SEM组（SEM-L组，25 µmol/L）、中剂量SEM组（SEM-M组，50 µmol/L）、高剂量SEM组（SEM-H组，100 µmol/L）、高剂量SEM+Compound C（AMPK抑制剂）组（SEM-H+Compound C组，100 µmol/L+10 µmol/L），所有各组Eca109细胞在对应的药物浓度下处理48 h后，CCK-8法检测Eca109细胞增殖，流式细胞术检测细胞凋亡，透射电镜观察Eca109细胞内自噬小体，WB法检测Eca109细胞中微管相关蛋白1轻链3（LC3）-Ⅱ/LC3-Ⅰ、Beclin-1、B淋巴细胞瘤2（Bcl2）、Bcl2相关X蛋白（BAX）、p-AMPK、SIRT1、p-NF-κB p65的表达。结果: 通过预实验选择SEM实验浓度为25、50、100 μmol/L用于正式研究。在SEM处理下，与CK组比较，SEM-L组、SEM-M组、SEM-H组Eca109细胞的增殖水平（24、48 h）和Bcl2、p-NF-κB p65蛋白表达均显著降低，细胞凋亡率和自噬小体数量、LC3-Ⅱ/LC3-Ⅰ、Beclin-1、BAX、p-AMPK、SIRT1蛋白表达显著升高，且呈剂量依赖性（均P<0.05）；与SEM-H组比较，SEM-H+Compound C组Eca109细胞增殖水平（24、48 h）和Bcl2、p-NF-κB p65蛋白表达均显著升高，细胞凋亡率和自噬小体数量、LC3-Ⅱ/LC3-Ⅰ、Beclin-1、BAX、p-AMPK、SIRT1蛋白表达均显著降低（均P<0.05）。结论:SEM可能通过激活AMPK/SIRT1信号通路而抑制NF-κB活性来促进Eca109细胞自噬与凋亡。

<b>Objectiveb> To explore the physician-pharmacist joint outpatient service mode of chronic obstructive pulmonary disease ( COPD) and asthma. <b>Methodsb> Cases of COPD or asthma patients who visited the joint outpatient department from June 2021 to December 2021 were collected in our hospital, the inhaler usage score，compliance ( MMAS-8) score，clinical control efficacy，incidence of adverse reactions and patient satisfaction were evaluated before and after pharmaceutical care intervention and statistically analyzed．<b>Resultsb> The inhaler usage score，MMAS-8 score，and the Asthma Control Test（ACT）/COPD Assessment Test（CAT） score had been changed significantly after the intervention (P<0.05). Patient satisfaction with pharmaceutical care was basically above 94.75%．<b>Conclusionb> Pharmaceutical care provided by joint outpatient department in our hospital could help COPD and asthma patients to use inhaler device correctly，resulting in improving compliance of inhaler usage, better disease control，and reducing the occurrence of adverse drug reactions, which could be a positive attempt and exploration of standardized pharmaceutical care model for patients with COPD and asthma．

In the present study, serum samples from 402 sheep and 216 goats were collected from 5 counties in Jinzhou from August to October 2012 and antibodies to Toxoplasma gondii were detected by modified agglutination test (MAT). Overall, 104 (16.8%) had antibodies to T. gondii with antibody titres of 1:25 to 1:800. Seropositive samples were distributed in all the 5 counties and seroprevalences of T. gondii varied significantly with flock size, age and rearing system, but not with breed, gender and farm location. The seroprevalences in small farms (18.3%, 95/518, 95% confidence interval [CI], 15.0-21.7%) were statistically higher than that in large farms (9%, 9/100, 95% CI, 3.4-14.6%) (P < 0.05), older animals were statistically higher than that in younger animals (P < 0.01). The prevalence in extensively and semiintensively raised samples was statistically higher than that in intensively raised animals (P < 0.01). Small flock size and extensive rearing system are the potential risk factors for the prevalence of Toxoplasma infection in sheep and goats in Jinzhou. This is the first report of T. gondii infection in sheep and goats in Jinzhou, northeastern China, and of an association of seropositivity to T. gondii and the risk factors.

Objective: To discuss the changes in the tight junction protein of intestinal epithelium and permeability of colonic mucosa and its possible mechanism by building the rat mode of inflammatory bowel disease at the chronic recovery stage. Methods: A total of 36 SD rats were divided into the model group and control one according to the random number table, with 18 rats in each group. Rats in the model group were given the 3% dextran sulfate sodium solution by the way of drinking for 7 d to build the rat model of inflammatory bowel disease, while rats in the control group were given free drinking of water. Six rats were executed at day 7, 14 and 21 respectively. The colonic tissues were collected from rats to observe the pathological changes of colonic mucosa. The activity of myeloperoxidase was detected and the white blood count was performed for rats in each group. The Ussing chamber technique was employed to detect the transepithelial electrical resistance (TER) and short-circuit current (SC) of colonic mucosa of rats in different time intervals; the quantum dots labeling technique was employed to detect the expression level of claudin-1 and claudin-2 in the colonic tissues. Results: After the successful modeling, the weight of rats in the model group was significantly reduced, while the disease activity index score was increased. The weight was at the lowest level at day 14 and then it began to increase afterwards. The disease activity index score was at the highest level at day 12 and then it began to decrease gradually. The activity of myeloperoxidase and WBC for rats in the model group all reached the peak value at day 14 and then decreased gradually. There was no significant difference in the changes of TER and SC in different time intervals for rats in the control group (P > 0.05). TER of model group was at the lowest level at day 14 and then increased gradually; SC was at the highest level at day 14 and then decreased gradually. TER of model group at day 7, 14 and 21 was significantly lower than that of control group, while SC of model group was significantly higher than that of control group (P < 0.05). There was no significant difference in the change of mean fluorescence intensity of claudin-1 and claudin-2 in different time intervals for rats in the control group (P > 0.05). The claudin-1 and claudin-2 for rats in the model group reached the highest level at day 14 and then decreased gradually. The claudin-1 and claudin-2 of model group at day 7, 14 and 21 was significantly higher than that of control group (P < 0.05). Conclusions: After the acute stage, the inflammatory bowel disease is then in the chronic recovery stage; the increased permeability of colonic mucosa and increased expression of tight junction protein of intestinal epithelium are closely related to the pathogenesis and development of disease. The tight junction protein plays a key role in the pathogenesis of injured colonic barrier of inflammatory bowel disease.

[摘 要] 目的：探讨同源重组修复（HRR）基因突变对晚期非小细胞肺癌（NSCLC）患者免疫治疗疗效和预后的影响。方法：收集2018年3月至2023年4月间在郑州大学第一附属医院接受PD-1抑制剂治疗的124例晚期NSCLC患者的临床资料。根据有无HRR基因突变将患者分为突变组（n=57例）和野生组（n=67例），采用卡方检验或Fisher’s精确检验比较两组患者的临床特征及免疫治疗疗效差异，采用Kaplan-Meier方法比较两组患者的PFS，采用单因素和多因素Cox回归分析PFS的影响因素。结果：HRR基因突变组中鳞癌及肿瘤突变负荷（TMB）≥10 mut/Mb的占比显著多于野生组（54.4% vs 32.8%，61.4% vs 29.9%，均P<0.05）。HRR基因突变组与野生组患者的ORR分别为17.5%和10.4%（P=0.252），DCR分别为86.0%和73.1%（P=0.080）。HRR基因突变组与野生组的PFS比较差异具有统计学意义（6.8个月 vs 3.9个月，P<0.001）。多因素分析结果显示，有无HRR基因突变[HR=0.550，95%CI（0.352, 0.860）, P=0.009]与免疫治疗线数[HR=0.468，95%CI（0.312, 0.702）, P<0.001]和PFS显著相关。结论：HRR基因突变组患者的免疫治疗疗效优于野生组患者，HRR基因突变是晚期NSCLC患者免疫治疗预后的独立保护因素。